Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,805 | -540 |
| Depreciation Amortization | 1 | 0 |
| Accounts payable and accrued liabilities | 37 | 14 |
| Other Working Capital | 176 | 14 |
| Other Operating Activity | 1,136 | 280 |
| Operating Cash Flow | $-455 | $-231 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -4 | -2 |
| Investing Cash Flow | $-4 | $-2 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,047 | N/A |
| Financing Cash Flow | $1,047 | $N/A |
| Beginning Cash Position | 184 | 416 |
| End Cash Position | 771 | 184 |
| Net Cash Flow | $587 | $-232 |
| Free Cash Flow | ||
| Operating Cash Flow | -455 | -231 |
| Capital Expenditure | -4 | -2 |
| Free Cash Flow | -459 | -232 |